InsidersTradesSigma
Browse the full record of transactions filed by Johannes Hulthe, Director. Director active across 2 companies, notably Guard Therapeutics International AB (publ). In total, 1 reports have been published. Activity tracked since 4 April 2025. The latest transaction was filed on 4 April 2025 (Purchase). Regulator: FIN-FSA. The full history is openly available.
1 of 1 declaration
Johannes Hulthe is a Board Member at Guard Therapeutics International AB (publ). He participates in strategic decisions and the governance of the company. His experience is valuable in guiding Guard Therapeutics in its research and development initiatives. Guard Therapeutics focuses on developing innovative treatments.